Medicare Enrolled
Dr. Maheep Birdi, MD
Neurology · Bakersfield, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Birdi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Birdi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Birdi
Dr. Maheep Birdi is a neurology specialist in Bakersfield, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Birdi performed 47,448 Medicare services across 4,965 unique beneficiaries.
Between the years covered by Open Payments, Dr. Birdi received a total of $45,273 from 78 pharmaceutical and/or device companies across 1360 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Birdi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 2% volume in CA
$45,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗47,448
Medicare services
Top 2% in CA for neurology
4,965
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
37,200 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
4,558 | $66 | $192 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
1,479 | $0 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
961 | $11 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
707 | $122 | $351 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $91 | $272 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
469 | $1 | $20 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
406 | $361 | $984 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
286 | $4 | $11 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
256 | $45 | $132 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
177 | $133 | $412 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
134 | $124 | $318 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
107 | $165 | $583 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
41 | $145 | $372 |
| Trigeminal nerve block injection An injection of an anesthetic agent into the trigeminal nerve bundle to numb the area. |
35 | $165 | $568 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
33 | $82 | $303 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
21 | $3 | $30 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 17 | $212 | $588 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $146 | $380 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$45,273
Total received (2018-2024)
Avg $6,468/year across 7 years
Top 9% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
1,360
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,468 (54.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,805 (46.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$27,162
2023
$3,238
2022
$3,413
2021
$3,512
2020
$2,339
2019
$3,283
2018
$2,326
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$23,667
Medtronic, Inc.
$422
Teva Pharmaceuticals USA, Inc.
$311
PFIZER INC.
$279
EMD Serono, Inc.
$271
ARGENX US, INC.
$233
ACADIA Pharmaceuticals Inc
$214
Otsuka America Pharmaceutical, Inc.
$197
Lundbeck LLC
$193
SK Life Science, Inc.
$177
Amgen Inc.
$159
UCB, Inc.
$153
Amneal Pharmaceuticals LLC
$119
Sumitomo Pharma America, Inc.
$98
AstraZeneca Pharmaceuticals LP
$68
Alexion Pharmaceuticals, Inc.
$68
Eisai Inc.
$66
Neurelis, Inc.
$65
Biogen, Inc.
$55
Grifols USA, LLC
$49
Neurocrine Biosciences, Inc.
$44
Kyowa Kirin, Inc.
$37
CSL Behring
$36
Lilly USA, LLC
$33
Novartis Pharmaceuticals Corporation
$31
Merz Pharmaceuticals, LLC
$28
Celgene Corporation
$21
JAZZ PHARMACEUTICALS INC.
$20
Genentech USA, Inc.
$20
Octapharma USA, Inc.
$16
Nevro Corp.
$14
Top 3 companies account for 89.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$24,299
LivaNova USA, Inc.
$1,189
AbbVie Inc.
$1,172
Novartis Pharmaceuticals Corporation
$1,159
EMD Serono, Inc.
$1,136
Supernus Pharmaceuticals, Inc.
$1,075
ACADIA Pharmaceuticals Inc
$945
Teva Pharmaceuticals USA, Inc.
$856
Biogen, Inc.
$825
Allergan, Inc.
$679
Alexion Pharmaceuticals, Inc.
$671
Amgen Inc.
$628
Sunovion Pharmaceuticals Inc.
$617
PFIZER INC.
$598
Medtronic, Inc.
$576
Lilly USA, LLC
$537
Kyowa Kirin, Inc.
$484
SK Life Science, Inc.
$402
Janssen Pharmaceuticals, Inc
$381
Medtronic Vascular, Inc.
$368
ARGENX US, INC.
$344
Lundbeck LLC
$339
AstraZeneca Pharmaceuticals LP
$328
Amneal Pharmaceuticals LLC
$323
Allergan Inc.
$315
Acorda Therapeutics, Inc
$308
UCB, Inc.
$302
Adamas Pharmaceuticals, Inc.
$246
Ivoclar Vivadent, Inc.
$246
Otsuka America Pharmaceutical, Inc.
$245
Sumitomo Pharma America, Inc.
$243
Vanda Pharmaceuticals Inc.
$226
Neurocrine Biosciences, Inc.
$199
Eisai Inc.
$167
Biohaven Pharmaceutical Holding Company Ltd.
$164
Abbott Laboratories
$163
Merz North America, Inc.
$150
Neurelis, Inc.
$144
Biohaven Pharmaceuticals, Inc.
$131
Nevro Corp.
$128
Horizon Therapeutics plc
$126
Akcea Therapeutics, Inc.
$119
Mallinckrodt LLC
$116
Zyla Life Sciences, Inc.
$112
Avanir Pharmaceuticals, Inc.
$109
EISAI INC.
$93
Ipsen Biopharmaceuticals, Inc
$90
Takeda Pharmaceuticals U.S.A., Inc.
$87
MITSUBISHI TANABE PHARMA AMERICA, INC.
$84
Strongbridge US INC.
$78
Averitas Pharma Inc.
$76
GRT US Holding, Inc.
$69
Celgene Corporation
$66
CSL Behring
$65
Genentech USA, Inc.
$63
Grifols USA, LLC
$49
AbbVie, Inc.
$47
ARBOR PHARMACEUTICALS, INC.
$44
Bayer HealthCare Pharmaceuticals Inc.
$41
GENZYME CORPORATION
$41
MDD US Operations, LLC
$38
IMPEL PHARMACEUTICALS INC.
$35
Arbor Pharmaceuticals, Inc.
$34
Boston Scientific Corporation
$32
Octapharma USA, Inc.
$31
Merz Pharmaceuticals, LLC
$28
Alnylam Pharmaceuticals Inc.
$25
Scilex Pharmaceuticals Inc.
$24
JAZZ PHARMACEUTICALS INC.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$17
E.R. Squibb & Sons, L.L.C.
$15
Upsher-Smith Laboratories LLC
$15
Tactile Systems Technology Inc
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
UPSHER-SMITH LABORATORIES LLC
$13
Ceribell, Inc.
$12
Impax Laboratories, Inc.
$12
Piramal Imaging Limited
$10
Top 3 companies account for 58.9% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · ASCENDA · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COMIRNATY · CREXONT · Ceribell Rapid Response EEG · DAYBUE · DUOPA · DYSPORT · Deep Brain Stimulation · Duopa · ELIQUIS · EMGALITY · EPIDIOLEX · Enspryng · FLEXITOUCH · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · HETLIOZ · Hetlioz · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEQEMBI · LEQVIO · LYRICA · Leqembi · LifeVest · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Omnia · Ongentys · PANZYGA · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELISTOR · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPRIX · Senza · Soliris · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XARELTO · XEOMIN · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for neurology in CA.
Geographic Context
Neurologists within 10 mi
18
Per 100K population
2.0
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
4.6 mi
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Birdi is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with speaking/promotional industry engagement in the top 9% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Birdi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Birdi performed 37,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Birdi receive payments from pharmaceutical companies?
Yes. Dr. Birdi received a total of $45,273 from 78 companies across 1,360 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Birdi's costs compare to other neurologists in Bakersfield?
Dr. Birdi's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Birdi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bakersfield
Browse neurologists in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology